Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure

MLA

Zhou X, et al. “Plasma Thrombomodulin as a Candidate Biomarker for the Diagnosis and Prognosis of HBV-Related Acute-on-Chronic Liver Failure.” Infection and Drug Resistance, vol. ume 17, Mar. 2024, pp. 1185–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.780c8bd894ad4b1e96ae8cbe418b45a8&authtype=sso&custid=ns315887.

APA

Zhou X, Luo J, Liang X, Li P, Ren K, Shi D, Xin J, Jiang J, Chen J, He L, Yang H, Ma S, Li B, & Li J. (2024). Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure. Infection and Drug Resistance, ume 17, 1185–1198.

Chicago

Zhou X, Luo J, Liang X, Li P, Ren K, Shi D, Xin J, et al. 2024. “Plasma Thrombomodulin as a Candidate Biomarker for the Diagnosis and Prognosis of HBV-Related Acute-on-Chronic Liver Failure.” Infection and Drug Resistance ume 17 (March): 1185–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.780c8bd894ad4b1e96ae8cbe418b45a8&authtype=sso&custid=ns315887.